Skip to content

Hub Group

US · HUBG #2876 by market cap Listed 1970
26.31 -1.85 -6.57%
Live - 5344 symbols - heartbeat 554s ago · 2026-10-07 19:54
After-hours 26.31 0.00%
Market cap
1.61B
P/B
0.95
EPS
1.70
Reader sentiment Are you bullish or bearish on HUBG?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good
  • Altman Z-Score is 3.42, above the 3.0 "safe zone" threshold.
  • Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year -6.10% YoY

Margins

Gross margin
11.11%
Operating margin
3.52%
Net margin
2.64%

Key ratios & quality

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item 2017 2018 2019 2020 2021 2022 2023 2024
Revenue 3.12B3.68B3.67B3.50B4.23B5.34B4.20B3.95B
Gross profit 337.63M445.60M521.07M425.44M470.26M760.98M503.66M438.36M
Selling & admin expenses 252.81M304.06M340.17M288.37M134.51M178.64M154.75M157.88M
Research & development ----------------
Operating profit 72.67M124.92M152.42M105.83M219.28M450.55M205.40M139.02M
Pretax profit 66.93M116.73M143.87M96.10M230.91M467.96M209.20M132.55M
Tax -53.08M29.06M36.70M22.54M59.44M111.01M41.68M28.50M
Net profit 135.15M201.74M107.17M73.56M171.47M356.95M167.53M104.04M
Basic EPS 23213532
Diluted EPS 2.033.011.601.102.535.322.621.70

Balance sheet

Line item 2017 2018 2019 2020 2021 2022 2023 2024
Total current assets 656.06M588.69M640.22M672.84M894.29M1.06B849.25M768.33M
Cash & ST investments 28.56M61.44M168.73M124.51M159.78M286.64M187.27M98.25M
Inventory ----------------
Total assets 1.67B1.92B1.99B2.11B2.44B2.81B2.94B2.87B
Total current liabilities 519.54M526.76M507.36M529.11M687.07M691.77M658.21M579.48M
Short-term debt 80.04M104.56M106.31M105.45M109.89M132.46M151.38M146.16M
Long-term debt 214.81M229.07M186.93M176.80M177.48M240.72M245.57M164.36M
Total liabilities 901,069,000.00944,064,000.00916,295,000.00947,473,000.001,096,980,000.001,210,479,000.001,301,402,000.001,176,392,000.00
Total equity 769.87M980.83M1.08B1.16B1.34B1.60B1.63B1.69B
Retained earnings 870.72M1.07B1.18B1.25B1.42B1.78B1.95B2.02B

Cash flow

Line item 2017 2018 2019 2020 2021 2022 2023 2024
Operating cash flow 125.22M210.84M254.51M174.95M252.84M458.16M422.16M194.42M
Depreciation & amortization 62.17M83.91M116.89M123.68M130.63M153.73M184.45M192.56M
Free cash flow 50.68M11.05M159.66M59.65M119.88M239.02M282.09M143.57M
Dividends paid ----------00-30.25M
Stock buybacks / issuance -3.41M-4.27M-28.98M-7.96M-9.12M-118.08M-153.92M-79.06M
Ending cash balance 28.56M61.44M168.73M124.51M159.78M286.64M187.27M126.95M

Returns & efficiency

Line item 2017 2018 2019 2020 2021 2022 2023 2024
ROE % 19.3323.0510.426.5913.7324.2810.366.34
ROA % 8.9211.225.473.597.5513.605.833.59
ROIC % 14.8317.398.375.6111.2719.497.995.04
5-year avg ROE % 12.8614.8715.1814.2214.6215.6113.0812.26
EBIT margin % 2.423.434.223.035.638.895.303.73
FCF / sales % 1.260.304.351.712.834.486.713.64
Current ratio 1.261.121.261.271.301.531.291.33
Quick ratio 0.881.061.211.221.261.461.201.19
Debt / assets 18.1117.5816.2515.1313.2216.0819.6017.73
LT debt / equity 28.9023.8420.2118.4115.8519.9625.9522.03
Interest coverage 14.4613.1414.0910.8632.6071.5616.5710.16
Revenue CAGR (3Y) % -4.371.4710.073.834.7413.346.33-2.31
Net income CAGR (3Y) % 37.8841.6712.73-18.35-5.2749.3431.57-15.34
FCF CAGR (3Y) % ---50.05--5.58121.3914.4067.856.20

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail
  • Intermodal and Transportation Solutions (ITS) is the largest reported line at 60.08% of revenue, across 3 reported segments.
  • Logistics follows at 43.06%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Intermodal and Transportation Solutions (ITS)60.08%
Logistics43.06%

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.